Epstein-Barr virus infection
Clinical trials for Epstein-Barr virus infection explained in plain language.
Never miss a new study
Get alerted when new Epstein-Barr virus infection trials appear
Sign up with your email to follow new studies for Epstein-Barr virus infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a nanoparticle vaccine stop the virus behind mono and some cancers?
Vaccine CompletedThis early-stage trial is testing whether a new vaccine can safely train the immune system to fight Epstein-Barr virus (EBV), which causes infectious mononucleosis and is linked to several cancers. Healthy adults aged 18 to 29, both with and without prior EBV infection, will rece…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Aug 15, 2026 00:00 UTC
-
Could a vaccine finally stop the 'Kissing Disease'?
Vaccine CompletedThis study tested a new vaccine designed to prevent Epstein-Barr virus (EBV) infection, which causes most cases of infectious mononucleosis (mono). Twenty-five healthy adults aged 18 to 25 who had never been infected with EBV received either the vaccine or a placebo. The goal was…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC